HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denise Cunningham Selected Research

OT-551

12/2010Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denise Cunningham Research Topics

Disease

4Geographic Atrophy
03/2024 - 12/2010
3Macular Degeneration (Age-Related Maculopathy)
03/2024 - 12/2010
3Atrophy
08/2021 - 09/2010
1Hyperpigmentation
03/2024
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2023
1Neoplasms (Cancer)
01/2019
1Hypopigmentation (Hypomelanosis)
01/2019
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
01/2019
1Albinism
01/2019
1Eye Abnormalities (Eye Abnormality)
01/2019
1Choroidal Neovascularization
01/2015
1Uveitis
03/2014
1Stargardt Disease
02/2012
1Melanoma (Melanoma, Malignant)
09/2010
1Gliosis
09/2010
1Ganglion Cysts (Ganglion)
09/2010
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2010

Drug/Important Bio-Agent (IBA)

6Retinaldehyde (Retinal)IBA
01/2023 - 09/2010
2Melanins (Melanin)IBA
01/2019 - 02/2012
2Retinal Pigments (Pigments, Visual)IBA
12/2016 - 02/2012
2Sirolimus (Rapamycin)FDA Link
12/2014 - 04/2013
1Minocycline (Cyclops)FDA LinkGeneric
03/2024
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
03/2024
1GTP Phosphohydrolases (GTPases)IBA
01/2023
1nitisinone (Orfadin)FDA Link
01/2019
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2019
1Ranibizumab (Lucentis)FDA Link
01/2015
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2015
1N-acetyltryptophanamide (NATA)IBA
01/2015
1Fluorescein (Funduscein)FDA LinkGeneric
03/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2013
1LipofuscinIBA
02/2012
1Hydroxylamine (Hydroxylamine Hydrochloride)IBA
12/2010
1AntioxidantsIBA
12/2010
1OT-551IBA
12/2010
1AntibodiesIBA
09/2010
1fludarabineIBA
09/2010

Therapy/Procedure

1Therapeutics
03/2024
1Topical Administration
12/2010
1Aftercare (After-Treatment)
09/2010
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2010
1Stem Cell Transplantation
09/2010